Novartis | NOVN - Current Assets

Stock Price
123.20
Daily Change
0.30 0.24%
Monthly
-2.53%
Yearly
26.62%
Q2 Forecast
116.14

Novartis reported $30.46B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Alcon AG USD 6.45B 116M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Autolus Therapeutics Ltd USD 435.92M 78.66M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 30.46B 2.26B Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Orion EUR 1.34B 247.2M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Philips EUR 9.93B 654M Dec/2025
Recordati EUR 1.71B 144.32M Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 6.05B 733M Dec/2025